for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Gilead Sciences And Second Genome Announce Collaboration In Biomarker And Inflammatory Bowel Disease Drug Discovery

April 6 (Reuters) - Gilead Sciences Inc:

* GILEAD SCIENCES AND SECOND GENOME ANNOUNCE STRATEGIC COLLABORATION IN BIOMARKER AND INFLAMMATORY BOWEL DISEASE DRUG DISCOVERY

* GILEAD SCIENCES INC - CO AND SECOND GENOME ENTERED INTO A FOUR-YEAR STRATEGIC COLLABORATION

* GILEAD SCIENCES INC - SECOND GENOME WILL RECEIVE $38 MILLION IN AN UPFRONT PAYMENT

* GILEAD SCIENCES INC - CO WILL HAVE OPTION TO WORLDWIDE RIGHTS FOR UP TO FIVE PROGRAMS FOR ALL DISEASES UNDER COLLABORATION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up